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We have previously reported that a Leishmania major lipophosphoglycan (LPG), given with killed 
Corynebacterium parvum as an adjuvant, can vaccinate mice against cutaneous leishmaniasis. In order to 
analyze whetber T ceUs are able to recognize this important parasite antigen, we have studied both humoral 
and ceUular immune responses to L. major LPG that bad been isolated from promastigotes by sequential 
solvent extraction and bydrophobic chromatography. Tbe data sbow that immunization of mice with highly 
purified LPG induced an increase in frequency of L. major-reactive T ceUs and the production of immuno-
globulin Gantibodies to LPG. Furthermore, geneticaUy resistant mice infected witb L. major were able to 
develop a specific delayed-type hypersensitivity responsein the ear to L. major LPG. These findings strongly 
soggest that T ceUs can recognize and respond to glycolipid antigens, in this case a bost-protective Leishmania 
LPG, even though such antigens appear nottobe potent T-ceU stimulators in mice. 
Leishmania spp. are digenetic protozoan parasites alter-
nating between the promastigote form in the sand fty vector 
and the obligatory intracellular amastigote form that resides 
in phagolysosomes of mammalian macrophages. Two para-
site molecules have been implicated in the process of inva-
sion of host macrophages, a glycoprotein (gp63) that binds to 
the complement receptor CR 3 on macrophages (2) and a 
lipophosphoglycan (LPG) (14). Both gp63 and LPG have a 
similar mode of anchoring into the parasite plasma mem-
brane via glycosyl inositol phospholipids (2, 25, 35) which 
resemble the membrane anchors of several eucaryotic pro-
teins (see reference 24 for a review), including the Trypano-
soma brucei variant surface glycoproteins (3, 8). 
Leishmaniamajor is the cause of cutaneous leishmaniasis, 
and the spectrum of disease pattems seen in humans can be 
reproduced in mice. Mice of genetically resistant inbred 
strains (e.g., C57BL/6) can control the infection, whereas 
genetically susceptible mice (e.g., BALB/c) develop pro-
gressive disease. A considerable body of experimental evi-
dence demonstrates the importance of T -cell-dependent im-
munity in both resistance and susceptibility to disease (18, 
23). Resistance to cutaneous leishmaniasis can be attributed 
to lymphokines with macrophage-activating properties pro-
duced by specifically sensitized T cells. There is evidence 
that these resistance-promoting T cells belong largely, if not 
exclusively, to the L3T4+ subpopulation (21, 28, 31). Vari-
ous L. major parasite antigen preparations have been shown 
to induce host protection in mice (9, 17, 39, 42), and there is 
considerable effort to develop a molecularly defined vaccine 
for immunoprophylaxis or immunotherapy of cutaneous 
leishmaniasis in humans. The two best-defined vaccine can-
didates are the parasite surface antigens gp63 and LPG, 
epitopes of at least the latter being detected on the surfaces 
of infected macrophages by using II}Onoclonal antibodies 
(15). 
Studies in our laboratory have focused on the biochemical 
and immunological characterization of L. major LPG. We 
have shown that intraperitoneal administration of the puri-
* Corresponding author. 
3349 
fied antigen with Corynebacterium parvum as an adjuvant 
can vaccinate genetically susceptible mice against cutaneous 
leishmaniasis (17, 25). In contrast, immunization with the 
hydrophilic carbohydrate (CHO) moiety of LPG, which is 
released into the culture supematant of promastigotes, is 
nonprotective and, when given with Freund complete adju-
vant, can exacerbate lesion development (29). In order to 
implicate T cells in protection, we have studied both hu-
moral and cellular immune responses to highly purified LPG 
from L. major. Here we present evidence that T cells 
recognize and are activated by LPG. Our data show that 
LPG-immunized mice contain an increased frequency of L. 
major-reactive T cells and produce T -cell-dependent immu-
noglobulin G (lgG) antibodies to LPG. Furthermore, mice 
infected with L. major parasites develop specific delayed-
type hypersensitivity (DTH) to L. major LPG. 
MATERIALS AND METHODS 
Mice. Fernale mice of the inbred strains BALB/c, BALB/ 
c.H-2k, and C57BL/6 were used at an age of 7 to 12 weeks. 
The mice were bred under specific pathogen-free conditions 
at the Walterand Eliza Hall Institute but durlog experimen-
tation were maintained under conventional conditions in an 
isolation facility. For some experiments, mice were pur-
chased from Charles River Breeding Laboratories, lnc., 
Sulzfeld, Federal Republic of Germany. 
Parasites and preparation of antigens. The cloned virulent 
L. major parasite line V121 was produced from human 
isolate LRC-L137 (16) that was initially obtained from the 
World Health Organization Reference Center for Leishma-
niasis, Jerusalem, Israel. For infection of mice, promasti-
gotes were grown in blood-agar cultures (13). Stationary-
phase promastigotes were washed, and 2 x 106 organisms 
were injected in a volume of 50 I-LI intradermally on the 
dorsum of the mouse close to the base of the tail. For 
preparation of antigen, promastigotes were grown in Schnei-
der Drosophila medium (GIBCO Laboratories, Grand ls-
land, N.Y.) supplemented with 10% fetal calf serum (Flow 
Laboratories, North Ryder, N.S.W., Australia). Antigen for 
DTH experiments and for in vitro stimulation of lympho-
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cytes was generated by UV irradiation (254 nm) of L. major 
promastigotes for 20 min. This treatment resulted in parasite 
death, as judged by staining with ethidium bromide-acridine 
orange (1 J.Lg/ml) and the failure to infect mice. Antigen was 
stored at - 20°C. 
L. major LPG was purified chemically from promastigotes 
by sequential solvent extraction and hydrophobic chroma-
tography on octyl-Sepharose (Pharmacia Fine Chemicals, 
Uppsala, Sweden), as described in detail by McConville et 
al. (25). Each batch of LPG was carefully checked for 
residual protein, both colorimetrically (Protein Assay; Bio-
Rad Laboratories, Richmond, Calif.) and by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (25). However, 
contamination with protein could not be detected, and the 
purity of the preparations is estimated to be greater than 
99.5%. The carbohydrate moiety (L. major CHO) was ob-
tained by incubating the purified LPG with phosphatidyli-
nositol-specific phospholipase C isolated from Staphylococ-
cus aureus (25), a generous gift from M. Low, Columbia 
University, New York, N.Y., and octyl-Sepharose chroma-
tography toseparate the hydrophilic (CHO) and hydropho-
bic (LPG) forms. 
Soluble Schistosomajaponicum egg antigenwas prepared 
by homogenization and sonication of eggs, followed by 
centrifugation (100,000 x g) and collection of the supema-
tant. A family of S. japonicum glycocol\iugates (termed 
ABCD) was obtained by affinity purification of S. japonicum 
egg antigen, using a series of monoclonal antiborlies that 
react with carbohydrate epitopes on S. japonicum eggs. The 
procedure is described in detail elsewhere (44a ), and the 
antigen preparations were kindly provided by W. U. Tiu. 
lmmunization. Multilaminated Iiposomes were prepared 
from dipalmitoyl phosphatidylcholine and dipalmitoyl phos-
phatidylserine (7:3, wt/wt; Sigma Chemical Co., St. Louis, 
Mo.). The Iipids (32 mg) were dried as a film, the L. major 
LPG (10 J.Lg) in phosphate-buffered saline (PBS) was added, 
and the whole mixture was vortexed. Mice were injected 
intraperitoneally with 10 J.L8 of LPG in Iiposomes together 
with 100 J.L8 of C. parvum (Wellcome Research Laboratories, 
Beckenham, England). Control groups ofmice were injected 
with C. parvum alone or with C. parvum and Iiposomes. 
lnjections were repeated after 20 days, and mice were 
challenged intradermally with 2 x 106 live L. major promas-
tigotes 14 days after the second immunization. Experimental 
groups consisted of five to seven mice. 
Assessment of antibody titers. Antibody titers in sera from 
immunized mice were assessed by using an enzyme-linked 
immunosorbent assay. The mice were bled 7 days after the 
second immunization (i.e., before infection with parasites) 
and 28 days after the challenge with live parasites. Sera from 
mice of the same experimental group were pooled. The 
enzyme-linked immunosorbent assays were performed in 
96-well round-bottom polyvinyl chloride plates (Dynatech 
Industries, Inc., Chantilly, Va.) in a volume of 50 J.LI per 
weil. For determination of anti-L. major antibodies, serial 
dilutions of sera were dispensed into wells precoated with 
lOs L. major promastigotes that bad been fixed with 0.25% 
glutaraldehyde in PBS (15). For determination of anti-LPG 
antibodies, the wells were precoated with poly-L-Iysine (5 
J.Lg/ml in distilled water) and L. major LPG (5 J.Lg/ml). Before 
the addition of serum, unsaturated binding sites were 
blocked with 1% skim milk powder-0.05% Tween 20 in PBS. 
After the serial dilutions of serum were incubated for 2 h at 
room temperature, the plates were washed repeatedly in 
PBS, horseradish peroxidase-coupled sheep anti-mouse 
immunoglobulins (Fab fragments; Silenus Laboratories, 
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Melbourne, Australia) were added, and the plates were 
incubated for 2 hat 37°C. For assessment ofimmunoglobulin 
isotypes, horseradish peroxidase-coupled goat anti-mouse 
immunoglobulin isotype-specific reagents (Southem Bio-
technology Associates, Birmingham, Ala.) were used. After 
a washing, the substrate 2,2'-azino-di-(3-ethylbenz-thiazo-
line-sulfonic acid) (ABTS; Sigma) was added, and the 
absorbance in the wells was read 30 min later with a Titertek 
Multiskau ML (Fiow Laboratories), using dual wavelengths 
(414 and 492 nm). Control wells lacking antibody consis-
tently gave an absorbance value of <0.01 optical density 
units. The units of antibody activity were calculated by 
correlating the dilution of the test sample with the dilution of 
the standard sample at a given optical density value in the 
linear range. The standard serum was an intemal standard 
that was chosen from a series of test sera (from LPG-
immunized mice), as it gave representative titers for all 
immunoglobulin isotypes. A 10-4 dilution of the standard 
serum at the respective optical density value in the linear 
range was defined as the titer corresponding to an antibody 
activity of 1,000 U. 
Limiting-dilution analysis. Spleen cell suspensions were 
prepared 7 days after the second immunization of mice with 
L. major LPG in Iiposomes and C. parvum. L3T4+ cells 
were obtained by treatment with anti-Ly-2 antibodies, from 
hybridoma YTS 169.4 (4), followed by incubation with rabbit 
complement, as described elsewhere (40). In some experi-
ments, the lymphocytes were immediately tested in limiting-
dilution analysis to determine the frequency of interleukin-2 
(IL-2)- and IL-3-producing precursor cells. In other experi-
ments, the responder cells were subjected to an additional 
cycle of in vitro restimulation and rest (37). A total of 3 x 106 
cells were cultured with 5 x 106 syngeneic irradiated (3,000 
rad) spieen accessory cells and 3 x 106 UV -irradiated L. 
major promastigotes in a total volume of 1.5 ml in ftat-
bottom culture wells. After 4 days, viable cells were isolated 
from the bulk cultures by centrifugation over Ficoii-Hy-
paque and placed into rest cultures consisting of 4 x lOs 
responder cells and 5 x 106 syngeneic spieen accessory 
cells, in the absence of antigen, for another 7 days. Viable 
cells were again isolated over Ficoll-Hypaque and tested by 
limiting-dilution analysis for the presence of IL-2- and IL-
4-secreting cells. 
Limiting numbers of lymphocytes were cultured in round-
bottom microdilution wells (Linbro; Flow Laboratories) 
with 2 x lOS irradiated (3,000 rad) syngeneic spieen acces-
sory cells from normal mice in 0.2 ml of a modified RPMI 
1640 culture medium (supplemented with 32 mM HEPES 
[N-2-hydroxyethylpiperazine-N' -2-ethanesulfonic acid], 10-4 
M 2-mercaptoethanol, and 10% fetal calf serum) containing 
15% supernatant from concanavalin A-stimulated rat spieen 
cell cultures as a source of IL-2. In some experiments, 
limiting-dilution cultures were supplemented with soluble L. 
major CHO (40 J.Lg/ml) that bad been prepared by affinity 
purification of L. major culture supernatant on a column 
containing monoclonal antibody WIC-79.3 (17). For each 
T -cell concentration ranging from 104 to 150 cells per weil, 
replicates of 24 wells were set up in the absence or presence 
of 2 x lOs UV -irradiated L. major promastigotes as a source 
of antigen. After 7 days of incubation (37°C, 10% C02), 
microcultures were washed three times to remove the super-
natant from the concanavalin A-stimulated rat spieen cell 
cultures and were restimulated by ad~ing 2 x lOs irradiated 
(3,000 rad) T-cell-depleted syngeneic spieen cells in the 
absence or presence of antigen (2 x 10 UV -irradiated L. 
major promastigotes), in 0.2 ml of culture medium. Twenty-
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four hours tf:lereafter, 0.15 ml of supematant was collected 
from each weil for the determination of lymphokine activity. 
Cultures containing T cells and accessory cells but no 
antigen were used as controls for each T-cell concentration. 
Antigen-stimulated microcultures were scored positive when 
the values of lymphokine activity exceeded the arithmetic 
mean of the control wells by more than 3 standard devia-
tions. Minimal estimates of the precursor frequency for each 
activity were obtained by the maximum-likelihood method 
from the Poisson distribution rel~tionship between the num-
ber of responding cells and the logarithm of the fraction of 
negative cultures (11). 
Assays for lympbokine activity. Microculture supematant 
was tested for IL-2 or IL-3 activity by incubation with the 
cloned IL-2-dependent T -cell line CTLL (10) or the IL-
3-dependent hematopoietic cell line 32D (12, 27), respec-
tively. The celllines were kindly provided by Anne Kelso of 
the Walter and Eliza Hall Institute. A 50-J.Ll volume of 
supematant was cultured with 4 x 103 CTLL cells or 2 x 1W 
32D cells in a total volume of 0.1 ml of RPMI 1640 culture 
medium in ftat-bottom microwells (Linbro; Flow Laborato-
ries). After 20 h (CTLL assay) or 44 h (32D assay), 1 J.LCi of 
[3H]thymidine was added forafurther 4 to 5 h. Cells were 
harvested onto glass fiber filter strips by using an automated 
cell harvester and counted in a liquid scintillation counter. 
For simultaneaus detennination of IL-2 and IL-4 activi-
ties, supematants from individual limiting-dilution cultures 
were divided into triplicate aliquots. Each aliquot of 50 J.Ll 
was tested for its ability to stimulate proliferation of 3 x 1W 
cells of the mouse HT-2 T-cell line (45) in a 0.1-ml ftat-
bottom culture weil. Mter 48 h, responsiveness was mea-
sured by using a modified colorimetric MTT [3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay (44). 
One aliquot was incubated in the absence of antibodies, to 
test for IL-2 and IL-4 activities. A second aliquot was tested 
in the presence of anti-IL-2 antibodies, from the hybridoma 
S4B6 (32), for the detennination of IL-4 activity. The third 
aliquot was tested in the presence of both anti-IL-2 and 
anti-IL-4 antibodies from the hybridoma llBll (34). 
Assay for DTH reactivity. The test antigen was adminis-
tered into the left ear of each mouse after the optimal 
concentration bad been determined according to a dose-
response curve for each individual antigen. A 10-J.Ll volume 
of the appropriate antigen concentration in PBS was injected 
intradennally, using a 100-J.Ll Rarnilton syringe mounted with 
a 30-gauge Yale needle. The right ear of each mouse re-
mained untreated. Mter 15, 24, and 48 h, the thicknesses of 
both ears were measured with an engineering micrometer, 
and the degree of swelling was expressed as the diJference in 
thickness of the antigen-injected and the control ears. Ex-
perimental groups offive to eight mice were infected with L. 
major promastigotes and tested for DTH reactivity at vari-
ous time points after infection. 
Preparation of tissues for bistology. Skin test sites were 
prepared for histological examination immediately after skin 
test reading. Mice were killed, and excised tissue was fixed 
in Bouin solution, embedded in paraffin wax, sectioned at 5 
J.LM, and stained with hematoxylin-eosin. 
RESULTS 
Immunization of mice witb L. llllljor LPG induces an 
increase in frequency of L. mtV"or-reactive T cells. Previous 
studies in our laboratory have shown that purified L. major 
LPG, injected with killed C. parvum as an adjuvant, vacci-
nates geneticaUy susceptible mice against cutaneous leish-
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TABLE 1. Frequency of L. major-reactive precursor T ceUs 
in mice immunized with L. major LPGa 
Treatment 
Reciprocal of frequency of lymphokine-producing cells 
(95% confidence Iimits) 
IL-2 IL-3 
LPG in Iiposomes 11,990 (8,795-18,832) 10,314 (7,716-15,576) 
+ C. parvum 
C. parvum 
None 
24,154 (16,000-49,261) 27,100 (18,348-51,813) 
ND6 95,740 (55,726-339,564) 
" Limiting numbers ofT cells from BALB/c.H-2k mice were cultured with 
syngeneic accessory cells in the presence or absence of L. major antigen and 
were restimulated 7 days later. At 24 h thereafter, supernatants from individ-
ual cultures were tested for IL-2 activity on CTLL ceUs or for IL-3 activity on 
320 cells. 
b ND, Not determined. 
maniasis (17, 25). In order to analyze whether immunization 
of susceptible mice with LPG and C. parvum induces the 
activation and expansion of L. major-specific T cells, we 
determined the frequency of precursor T cells that re-
sponded to L. major antigen by production of lymphokines. 
A limiting-dilution system was used for frequency estima-
tion. Lymphocytes were collected 7 days after the second 
immunization of BALB/c.H-2k mice with L. major LPG in 
Iiposomes and C. parvum. Lymphocytes from syngeneic 
control mice were used for comparison. Limiting numbers of 
nylon wool-purified T cells were stimulated in vitro with 
UV -inactivated L. major promastigotes and accessory cells 
in the presence of supematant from concanavalin A-stimu-
lated rat spieen cell cultures. As a control, a second series of 
limiting-dilution cultures was set up in the absence of antigen 
for each responder-cell population. For detection of L. 
major-reactive T cells, lymphokine production was found to 
be much more antigen specific, and gave considerably lower 
background activity, than lymphoproliferation. Hence, su-
pematants from individual microcultures were split and 
assayed for IL-2 and IL-3 activities as a readout, in the 
limiting-dilution analysis, for responsiveness. Table 1 sum-
marizes the frequencies of L. major-specific precursor T 
cells from LPG-immunized and control mice. The data show 
that the frequency of lymphokine-producing T cells in- . 
creased more than twofold in mice immunized with LPG 
(IL-2, 1/11,900; IL-3, 1/10,314), compared with those ofmice 
injected with C. parvum alone (IL-2, 1/24,154; IL-3, 11 
27,100). Treatment with C. parvum alone also resulted in 
some stimulation of T -cell activity over that seen in un-
treated mice (frequency UJ = 1195,740). 
In a further experiment, it was attempted to characterize 
the type ofT cell that is being activated. Forthis purpose, 
purified L3T4 + cells from BALB/c mice were used in 
limiting-dilution analysis. and the culture supematants were 
tested on HT-2 cells, in the presence or absence ofanti-IL-2 
antibodies, for IL-2 and IL-4 production. As reported pre-
viously (37), it was difficult to detect IL-4-producing cells in 
cultures of freshly prepared lymphocytes from antigen-
primed mice. However, IL-4 secretion could be demon-
strated in limiting-dilution cultures set up after a cycle of in 
vitro restimulation with L. major antigen and an inteval of 
culture in the absence of antigen (37). The frequency of 
restimulated L. major-reactive L3T4+ cells with lymphokine 
activity (IL-2 and IL-4) was very much higher in LPG-
treated mice (1/258; 95% confidence Iimits, 11198 to 1/370) 
than in control mice treated only with Iiposomes and C. 
parvum (1/6,274; 95% confidence Iimits, 1/3,473 to 1/32,124). 
When the culture supematants were assayed in the presence 
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T ABLE 2. Effect of soluble L. major CHO on frequency of L. major-reactive precursor T cellsa 
Expt Cells Culture supplement 
1 T None 
L. majorCHO 
2 None 
L. majorCHO 
Reciprocal of frequency of lymphokine-producing cells 
(95% confidence Iimits) in the presence of: 
No antibodies 
4,328 (3,121-7,056) 
18,053 (11,954-36,310) 
935 (67~1.551) 
3,195 (1,831-12,558) 
Anti-IL-2 
NDb 
ND 
6,742 (4,814-11,169) 
15,020 (10,404-27,043) 
a All BALB/c mice were treated with LPG in Iiposomes and C. parvum. After a cycle of in vitro Stimulation with L. major antigen followed by an interval of 
culture in the absence of antigen, limiting numbers of selected spieen cells were cultured with syngeneic accessory cells and L. mqjor antigen. Cultures were 
restimulated 7 days later, and 24 h thereafter, supernatants were collected and tested for lymphokine activity on HT-2 cells in the presence or absence of anti-IL-2 
antibodies. Limiting-dilution cultures were set up and restimulated in the presence or absence of 40 J.1.8 of soluble L. major CHO per ml. 
b ND, Not determined. 
of anti-IL-2 antibodies, residual activity if = 1/1,197; 95% 
confidence Iimits, 1/919 to 1/1,712) could be detected only in 
cultures containing T cells from LPG-immunized animals 
(for control mice, f < 1/100,000). All this remaining activity 
was inhibited when the supernatants were tested in the 
additional presence of anti-IL-4 antiborlies ( data not shown), 
indicating that it could in fact be attributed to IL-4. These 
data demoostrate that immunization of mice with LPG 
results in the induction of both IL-2- and IL-4-producing L. 
major-specific L3T4+ cells. 
The addition to limiting-dilution cultures of the soluble 
CHO moiety of L. major LPG, purified from promastigote 
culture supernatant, caused a significant reduction in fre-
quency of L. mqjor-reactive T cells (Table 2). This evidence 
for competitive inhibition by soluble L. major CHO suggests 
that a large proportion of L. major-reactive T cells from 
LPG-immunized mice recognizes a CHO epitope of LPG. 
The adrlition of mannan or dextran did not have any effect, 
demonstrating the specificity of the inhibition (data not 
shown). Conversely, L. major CHO dirl not block the 
response of lymphocytes from infected BALB/c mice to L. 
major promastigotes (data not shown). 
Immunization of mice with L. mlljor LPG induces a specific 
IgG antibody response. At 7 days after the second immuni-
zation of BALB/c.H-2k mice with L. major LPG in Iipo-
somes anrl C. parvum (i.e., before infection with parasites) 
as weil as 28 days after the subsequent challenge with viable 
L. major promastigotes, sera were collected from immu-
nized and control mice. The titers of serum antiborlies 
binding to either whole L. major promastigotes or purified 
LPG were determined in an enzyme-linked immunosorbent 
assay. The majority of antiborlies detected in immunized 
and/or infected mice belonged to the lgM anrl lgG1 sub-
classes, but there were also significant titers of lgG2a and 
lgG3 antiborlies (Fig. 1). No significant antibody response to 
L. major antigens could be detected in untreaterl mice or in 
mice injected with C. parvum alone. Antiborlies binding to 
epitopes on whole L. major promastigotes (Fig. 1, top) could 
be demonstrated in sera. from LPG-immunizerl mice before 
and after infection with parasites, as weil as in sera from L. 
major-infected control mice. On the other band, antiborlies 
binding to purifierl L. major LPG could be found only in mice 
treated with LPG (Fig. 1, bottom), with the exception of a 
low IgG1 titer in sera from infected control mice. lt is of 
particular interest that anti-LPG as well as anti-L. major 
antiborlies of the lgG3 isotype were detected exclusively in 
LPG-immunized mice. No lgE antiborlies coulrl be detected 
in sera of any of the experimental groups (rlata not shown). 
The total immunoglobulin content of the sera was deter-
minerl in an indepenrlent assay, using anti-mouse immuno-
::i 
0 
1000 
100 
anti-L.major tJ a Untreated c C.p. a LPG. C.p. • LPG. C.p. •L.m. • C.p.+ L.m. 
FIG. 1. Specific antibody titers in sera from mice immunized 
with L. major LPG. Afteradministration of LPG in liposomes and 
C. parvum (LPG, C.p.), as weil as after subsequent infection with L. 
major parasites (LPG, C.p. + L.m.), sera were collected from 
LPG-immunized and corresponding control mice (C.p.; C.p. + 
L.m.). The titers of serum antibodies binding to either whole L. 
major parasites (top) or purified L. major LPG (bottom) were 
determined by using an enzyme-linked immunosorbent assay. a.u., 
Arbitrary units, as defined in Materials and Methods. 
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FIG. 2. DTH reactivity of L. mtVor-infected C57BU6 (e) and BALB/c (0) mice to whole L. major promastigotes. Ear swelling was 
determined 24 h after local antigen challenge and at various days after infection. Animals were tested only once, and uninfected mice were 
used as a control. Vertical bars indicate the standard deviation of the arithmetic mean. 
globulins rather than isotype-specific antibodies as the sec-
ond-step reagent. Therefore, the titers are not directly 
comparable to those determined in the isotype assays; in the 
experiments reported here, they were lower than the sum of 
the isotype titers. In conclusion, the generation of LPG-
specific IgG antibodies in response to immunization of mice 
with purified L. major LPG in Iiposomes indicates that this 
glycolipid antigen can activate T cells in vivo to provide 
helper signals for the maturation of IgG-secreting B cells. 
L. major LPG induces DTH reactivity in infected mice. The 
data obtained from experiments with genetically susceptible 
mice immunized with L. major LPG in Iiposomes and C. 
parvum provide strong evidence for T -cell recognition of the 
purified LPG, as judged by an increased frequency of L. 
major-reactive T cells. and the apparent ability to mediate 
T -cell help for antibody production. In order to extend these 
results to an examination ofT -cell reactivity to purified LPG 
in vivo, we have assessed the capacity of LPG to elicit DTH 
reactivity in L. major-infected mice. 
In a control experiment, genetically susceptible BALB/c 
and genetically resistant C57BL/6 mice were challenged 
intradermally with a preparation of 106 UV -inactivated L. 
major promastigotes at various time points after infection 
with L. major parasites. At 15, 24, and 48 h after antigen 
injection into the ear, the increase in thickness of the 
injected ear was determined. The swelling peaked at 24 h and 
persisted beyond 48 h after ear challenge. The values for the 
24-h time point (Fig. 2) demoostrate that despite the differ-
ence in susceptibility to infection between BALB/c and 
C51BU6 mice, both strains exhibited a marked ear response 
to this crude preparation of Leishmania antigens (13). A 
positive reaction remained stable for 90 days of infection, at 
which time C57BL/6 mice had healed completely, whereas 
BALB/c mice exhibited typical large lesions. Histological 
examinations of the affected ear tissue showed a marked 
infiltration with mononuclear cells for both strains and thus 
confirmed the tuberculin-type nature of the DTH reaction 
measured (data not shown). Sex- and age-matched unin-
fected controls did not show a significant DTH reactivity. 
U sing a similar experimental protocol, L. major-infected 
C57BU6 and BALB/c mice were injected in the ears with 2.5 
JJ.g of purified L. major LPG. Resistant C57BL/6 mice were 
able to develop a DTH reaction to LI:'Q throughout the 
course of disease and sbowed significant ear swelling even 
after their lesions bad healed (Fig. 3). Challenge of L. 
major-infected mice with 0.1 JJ.g of a glycoconjugate isolated 
from the helminth worm S. japonicum did not result in ear 
swelling. In mice sensitized with S. japonicum eggs, how-
ever, this antigen did elicit a response. The fact that L. 
major-infected C57BL/6 mice developed a specific DTH 
response to purified L. major LPG suggests that LPG can 
activate antigen-specific T cells. 
When L. major-infected BALB/c mice were challenged 
with LPG, ear swelling was found at the onset of infection 
but not at later stages of chronic disease (Fig. 3). Further-
more, histological examinations showed that, in cantrast to 
C57BU6 mice, the LPG-induced DTH reaction in BALB/c 
mice was characterized by infiltration with polymorphs 
rather than mononuclear cells (data not shown). This finding 
suggests that the LPG-induced DTH response is qualita-
tively different in these two strains of mice. 
Lack of DTH reacüvity to the CHO moiety of L. major LPG. 
In contrast to the intact L. major LPG that can protect mice 
against cutaneous leishmaniasis (17, 25), the hydrophilic 
CH9 moiety derived from the LPG, when injected in Freund 
complete adjuvant, was shown to exacerbate disease (29). It 
was therefore of interest to assess the T-cell reactivity to L. 
major CHO, using the ear assay for DTH. At 25 and 61 days 
of infection, BALB/c and C57BU6 mice were injected in the 
ears with L. major CHO that had been prepared by enzy-
matic hydrolysis of the Iipid moiety from LPG. The glyco-
conjugate failed to induce significant swelling (Table 3). 
Using a dose of CHO that corresponded to that of LPG 
which elicited a marked response (2.5 JJ.g), there was no 
DTH reactivity to L. major CHO. 
DISCUSSION 
In the present report, we provjde evidence for T-cell 
recognition of a purified Leishmania glycolipi4 antigen that 
can vaccinate mice against cutaneous leishmaniasis. This is 
one of a growing number of examples ofT -cell recognition of 
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FIG. 3. DTH reactivity of L. major-infected C57BL/6 (closed symbols) and BALB/c (open symbols) mice to purified L. major LPG (e, 
0) or S.japonicum glycoconjugate (A, 6). Ear swelling was determined 24 h after local antigen challenge and at various days after infection. 
Animals were tested only once. Control groups consisted ofuninfected mice challenged with L. major LPG (e, 0), or of mice sensitized witb 
S. japonicum eggs (A). 
carbohydrate antigens (1, 7, 26, 36, 38, 43; for a review, see 
reference 5). 
For analysis ofT-cell responsiveness to L. major LPG, we 
used genetically susceptible mice that bad been immunized 
with LPG in Iiposomes and C. parvum as weil as genetically 
resistant and susceptible mice infected with L. major pro-
mastigotes. The LPG preparation used for these experiments 
was highly purified and free of detectable protein. The data 
demoostrate that immunization of mice with L. major LPG 
increased the frequency of L. major-reactive T cells with the 
capacity to secrete lymphokines. Immunization also resulted 
in the production of T-cell-dependent lgG antibodies to 
LPG. Finally, a most important finding was that LPG was 
able to elicit a specific tubercutin-type DTH reactivity in L. 
major-infected mice. This provides evidence, though still 
circumstantial, for in vivo activation of T cells by the 
purified L. major LPG. 
T -cell reactivity to L. major antigen in vitro was signifi-
cantly decreased by adding the soluble CHO moiety of LPG 
to the limiting-dilution cultures; i.e., L. major CHO presum-
ably competed for T -cell recognition of relevant antigenic 
structures. This finding strongly suggests that a large pro-
portion of L. major-reactive T cells from LPG-immunized 
mice is directed against a CHO epitope of LPG. It was noted 
that treatment of mice with C. parvum alone also resulted in 
TABLE 3. DTH reaction to the CHO moiety of purified L. major 
LPG in L. major-infected mice 
Increase in ear thickness (JLm ± SD)a 
Timeafter BALB/c C51BU6 infection (days) 
CHO L. mqjor CHO L. mqjor 
25 27 ± 12 190 ± 74 36 ± 24 146 ± 48 
61 27 ± 11 200 ± 49 54± 30 266 ± 18 
a The difference in thickness of the iqjected ear and the control ear was 
determined 24 h after challenge in the ears with either whole L. mqjor 
promastigotes or 2.5 1'-8 of L. major CHO prepared by enzymatic cleavage of 
purified L. mqjor LPG. SD, Standard deviation. 
a moderate increase in frequency of T cells releasing IL-2 
and IL-3. C. parvum, given alone, probably induces a 
polyclonal activation of tbese T cells, some of which would 
be directed to Leishmania antigens, whereas immunization 
with LPG in adjuvant presumably Ieads to tbe additional 
stimulation of antigen-specific T cells. IL-4 activity, on the 
other band, was detected only in LPG-immunized mice. We 
are currently analyzing in further detail the influence of LPG 
. on the cytokine pattems in L. major-infected and uninfected 
mice of various strains. 
DTH reactivity upon cballenge of infected mice with a 
preparation of whole L. major promastigotes did not corre-
late with the degree ofsusceptibility ofthe inbred mice used. 
Both genetically resistant C57BL/6 and genetically suscep-
tible BALB/c mice were able to develop a DTH response 
over a period of 90 days after infection. At this time, lesions 
bad completely resolved in C57BL/6 mice, whereas BALB/c 
mice suffered from chronic disease. In both strains of mice, 
the DTH reaction to this crude preparation of L. major 
antigens peaked at 24 to 48 h after cballenge in the ear. 
Histological examination did not reveal a qualitative differ-
ence, but infiltration witb mononuclear cells was less pro-
nounced in tissues frorn BALB/c mice. These results indi-
cate that a DTH response to crude antigen is not necessarily 
associated with a protective immune response, as has been 
observed by others (reviewed in reference 20). On the otber 
band, the DTH reaction in response to the purified L. major 
LPG correlated weil with resistance to cutaneous infection. 
Resistant C57BL/6 mice were able to respond to LPG 
throughout the course of disease and after healing, whereas 
susceptible BALB/c mice developed LPG-specific reactivity 
only at tbe onset of infection. Moreover, bistological exam-
ination of tbe skin test site revealed a predominant infiltra-
tion with polymorpbonuclear cells in BALB/c mice, whereas 
only mononuclear cells were found in C57BL/6 mice. This 
finding suggests that the LPG-specific response in BALB/c 
mice did not fulfill all the criteria of a classical DTH reaction. 
Tbus, DTH reactivity is different in genetically susceptible 
and genetically resistant mice, a conclusion that is supported 
VoL. 57, 1989 
by a recent report on düferences in the kinetics of DTH 
· responses to Leishmania antigen preparations, depending on 
the state of resistance of the inbred mice used (6). Gamma 
interferon has recently been shown to mediate lymphocyte 
recruitment into the skin during DTH reactions (19). This 
raises the possibility that LPG is able to stimulate the 
production of this lymphokine by T cells, but further studies 
are required to consolidate such an interpretation. 
In contrast to L. major LPG, which vaccinates mice 
against cutaneous leishmaniasis, the CHO moiety derived by 
enzymatic cleavage of LPG, when given with Freund com-
plete adjuvant, can exacerbate subsequent disease (29). 
Since the induction of proteelive immunity as weil as its 
impairment have been attributed to L. major-specific L3T4 + 
T-cell subpopulations (23), these findings favor the hypoth-
esis that the LPG molecule activates resistance-promoting 
L3T4+ T cells, whereas the CHO split product of LPG 
activates L3T4 + T cells that facilitate disease (30). This 
interpretation is supported by our finding that L. major-
infected mice of a resistant genotype develop a consistent 
DTH response to LPG, whereas genetically susceptible mice 
with chronic disease fail to respond. On the other band, we 
could not detect any DTH reactivity to purified L. major 
CHO, neither in resistant nor in susceptible mice. It is 
possible that L. major CHO is recognized by T helper cells 
of type 2 that are not able to mediate DTH reactions, 
whereas LPG stimulates T helper cells of type 1 that are 
capable of inducing DTH (33), possibly via secretion of 
gamma interferon (19). However, it should be noted that it is 
not clear yet whether the concept of different types of T 
helper cells, which has been established for cloned T cells, 
can similarly be applied to L3T4+ cells in vivo. Using T-cell 
clones, evidence that proteelive and exacerbative T cells 
belong to düferent T helper subsets and respond to distinct 
antigens has also been provided by a recent report (41). 
The presented evidence for T -cell recognition of the 
purified LPG molecule is based on the ability of LPG to elicit 
T-cell functions both in vivo and in vitro. lt will be of 
particular importance to extend the reported findings by 
using in vitro T-cell assay systems. They will facilitate· 
functional characterization at a clonal Ievel and a more 
precise quantification of the T-cell subsets involved in an 
anti-LPG immune response. Wehave been unable to detect 
direct T-cell responsiveness to soluble LPG in vitro. Current 
studies are aimed at increasing the efficiency of antigen 
presentation by using an appropriate antigen carrier and 
düferent sources of antigen-presenting cells. The final aim of 
these efforts is the identification and characterization of 
L3T4+ T cells promoting either resistance or susceptibility 
to cutaneous leishmaniasis. The analysis of their lymphokine 
patterns will be of particular interest because of recent 
evidence (22) for düferences in lymphokine production by 
lymphocytes from healer and nonhealer mice infected with 
L. major. The findings suggested that effective cellular 
immunity is reftected in the expansion of type 1 T helper 
cells, whereas the inability to control disease is accompanied 
by the expansion of type 2 T helper cells (33). 
lt has long been controversial whether T cells are capable 
of recognizing polysaccharide antigens. DTH reactivity to 
bacterial carbohydrates has repeatedly been reported (1, 7, 
38; reviewed in reference 5), but to our knowledge there has 
not been any report yet documenting direct and unequivocal 
T-cell responsiveness to pure carbohydrate or glycolipid 
antigens in vitro. However, there is accumulating evidence 
demonstrating the capacity of such antigens, obtained from 
bacteria, to modulate T-cell responses in vivo and in vitro 
T-CELL RECOGNITION OF L. MAJOR LPG 3355 
(26, 36, 43). The present report extends this growing evi-
dence to a highly purified parasite glycolipid antigen. 
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